- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.73 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x RN7: 2-[(4-amino-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(morpholin-4-yl)ethyl]acetamide(Non-covalent)
- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.2: 6 residues within 4Å:- Chain A: H.139, A.140, Q.311, E.421, F.422
- Ligands: RN7.1
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:H.139, A:D.312, A:F.422
- Water bridges: A:A.140
PEG.3: 12 residues within 4Å:- Chain A: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: SO4.5, NA.9
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:L.261, A:H.269, A:T.289
PEG.12: 6 residues within 4Å:- Chain B: H.139, A.140, Q.311, E.421, F.422
- Ligands: RN7.11
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:H.139, B:D.312, B:F.422
- Water bridges: B:A.140
PEG.13: 12 residues within 4Å:- Chain B: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: SO4.15, NA.19
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.261, B:H.269, B:T.289
PEG.22: 6 residues within 4Å:- Chain C: H.139, A.140, Q.311, E.421, F.422
- Ligands: RN7.21
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:H.139, C:D.312, C:F.422
- Water bridges: C:A.140
PEG.23: 12 residues within 4Å:- Chain C: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: SO4.25, NA.29
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:L.261, C:H.269, C:T.289
PEG.32: 6 residues within 4Å:- Chain D: H.139, A.140, Q.311, E.421, F.422
- Ligands: RN7.31
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:D.312, D:E.421, D:F.422
- Water bridges: D:A.140
PEG.33: 12 residues within 4Å:- Chain D: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: SO4.35, NA.39
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:L.261
PEG.42: 6 residues within 4Å:- Chain E: H.139, A.140, Q.311, E.421, F.422
- Ligands: RN7.41
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:D.312, E:E.421, E:F.422
- Water bridges: E:A.140
PEG.43: 12 residues within 4Å:- Chain E: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: SO4.45, NA.49
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:L.261
PEG.52: 6 residues within 4Å:- Chain F: H.139, A.140, Q.311, E.421, F.422
- Ligands: RN7.51
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:D.312, F:E.421, F:F.422
- Water bridges: F:A.140
PEG.53: 12 residues within 4Å:- Chain F: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: SO4.55, NA.59
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:L.261
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 5 residues within 4Å:- Chain A: H.125, R.126, R.317, M.319, R.373
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.317, A:R.317, A:M.319
- Water bridges: A:R.126
GOL.14: 5 residues within 4Å:- Chain B: H.125, R.126, R.317, M.319, R.373
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.317, B:R.317, B:M.319
- Water bridges: B:R.126
GOL.24: 5 residues within 4Å:- Chain C: H.125, R.126, R.317, M.319, R.373
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:R.317, C:R.317, C:M.319
- Water bridges: C:R.126
GOL.34: 5 residues within 4Å:- Chain D: H.125, R.126, R.317, M.319, R.373
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:R.317, D:R.317, D:M.319
- Water bridges: D:R.126
GOL.44: 5 residues within 4Å:- Chain E: H.125, R.126, R.317, M.319, R.373
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:R.317, E:R.317, E:M.319
- Water bridges: E:R.126
GOL.54: 5 residues within 4Å:- Chain F: H.125, R.126, R.317, M.319, R.373
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:R.317, F:R.317, F:M.319
- Water bridges: F:R.126
- 18 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 7 residues within 4Å:- Chain A: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.3
Ligand excluded by PLIPSO4.6: 5 residues within 4Å:- Chain A: W.33, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.7: 9 residues within 4Å:- Chain A: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.15: 7 residues within 4Å:- Chain B: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.13
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain B: W.33, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.17: 9 residues within 4Å:- Chain B: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.25: 7 residues within 4Å:- Chain C: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.23
Ligand excluded by PLIPSO4.26: 5 residues within 4Å:- Chain C: W.33, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.27: 9 residues within 4Å:- Chain C: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.35: 7 residues within 4Å:- Chain D: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.33
Ligand excluded by PLIPSO4.36: 5 residues within 4Å:- Chain D: W.33, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.37: 9 residues within 4Å:- Chain D: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.45: 7 residues within 4Å:- Chain E: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.43
Ligand excluded by PLIPSO4.46: 5 residues within 4Å:- Chain E: W.33, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.47: 9 residues within 4Å:- Chain E: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.55: 7 residues within 4Å:- Chain F: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.53
Ligand excluded by PLIPSO4.56: 5 residues within 4Å:- Chain F: W.33, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.57: 9 residues within 4Å:- Chain F: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIP- 18 x NA: SODIUM ION(Non-functional Binders)
NA.8: 8 residues within 4Å:- Chain A: R.88, L.89, T.90, V.96, R.203, G.209, L.210, L.211
Ligand excluded by PLIPNA.9: 7 residues within 4Å:- Chain A: L.261, H.269, W.273, I.287, T.289, D.293
- Ligands: PEG.3
Ligand excluded by PLIPNA.10: 7 residues within 4Å:- Chain A: G.150, L.316, R.317, I.318, R.373, D.374, G.377
Ligand excluded by PLIPNA.18: 8 residues within 4Å:- Chain B: R.88, L.89, T.90, V.96, R.203, G.209, L.210, L.211
Ligand excluded by PLIPNA.19: 7 residues within 4Å:- Chain B: L.261, H.269, W.273, I.287, T.289, D.293
- Ligands: PEG.13
Ligand excluded by PLIPNA.20: 7 residues within 4Å:- Chain B: G.150, L.316, R.317, I.318, R.373, D.374, G.377
Ligand excluded by PLIPNA.28: 8 residues within 4Å:- Chain C: R.88, L.89, T.90, V.96, R.203, G.209, L.210, L.211
Ligand excluded by PLIPNA.29: 7 residues within 4Å:- Chain C: L.261, H.269, W.273, I.287, T.289, D.293
- Ligands: PEG.23
Ligand excluded by PLIPNA.30: 7 residues within 4Å:- Chain C: G.150, L.316, R.317, I.318, R.373, D.374, G.377
Ligand excluded by PLIPNA.38: 8 residues within 4Å:- Chain D: R.88, L.89, T.90, V.96, R.203, G.209, L.210, L.211
Ligand excluded by PLIPNA.39: 7 residues within 4Å:- Chain D: L.261, H.269, W.273, I.287, T.289, D.293
- Ligands: PEG.33
Ligand excluded by PLIPNA.40: 7 residues within 4Å:- Chain D: G.150, L.316, R.317, I.318, R.373, D.374, G.377
Ligand excluded by PLIPNA.48: 8 residues within 4Å:- Chain E: R.88, L.89, T.90, V.96, R.203, G.209, L.210, L.211
Ligand excluded by PLIPNA.49: 7 residues within 4Å:- Chain E: L.261, H.269, W.273, I.287, T.289, D.293
- Ligands: PEG.43
Ligand excluded by PLIPNA.50: 7 residues within 4Å:- Chain E: G.150, L.316, R.317, I.318, R.373, D.374, G.377
Ligand excluded by PLIPNA.58: 8 residues within 4Å:- Chain F: R.88, L.89, T.90, V.96, R.203, G.209, L.210, L.211
Ligand excluded by PLIPNA.59: 7 residues within 4Å:- Chain F: L.261, H.269, W.273, I.287, T.289, D.293
- Ligands: PEG.53
Ligand excluded by PLIPNA.60: 7 residues within 4Å:- Chain F: G.150, L.316, R.317, I.318, R.373, D.374, G.377
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis fromMycobacterium tuberculosis. Acs Chem.Biol. (2020)
- Release Date
- 2020-06-03
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.73 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x RN7: 2-[(4-amino-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(morpholin-4-yl)ethyl]acetamide(Non-covalent)
- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 18 x SO4: SULFATE ION(Non-functional Binders)
- 18 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis fromMycobacterium tuberculosis. Acs Chem.Biol. (2020)
- Release Date
- 2020-06-03
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A